Wipro’s expertise in genomics and biomarker discovery will assist Avesthagen in developing well-regulated workflows during the development of CALiBRx® gene panels.  The tests would primarily be available in oncology-focused super specialty clinics and hospitals. Later, it will strategically release diagnostic tools for upper respiratory cancers such as head, neck, and esophageal cancers. The project would result in a new generation of genome-led medicine in the medium and long term…..READ MORE